Remotely Supervised Exercise During Chemotherapy in Women With Breast Cancer
ConditionBreast Cancer
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age30-65
SponsorRiga Stradins University
About this trial
The RE-CARE project is designed to evaluate the effects of a 24-week, remotely supervised, combined high-intensity interval aerobic and resistance exercise training on physical health and quality of life in patients with breast cancer (BC) undergoing neoadjuvant chemotherapy (NACT). The study will enroll women aged 30-65 years with previously untreated, primary breast cancer, clinical stage IIA-IIB or IIIA-IIIC, who are scheduled to receive doxorubicin/cyclophosphamide-based NACT. Participants will be randomly allocated to either an experimental intervention group or a control group. At baseline, comprehensive assessments will be conducted to evaluate cardiorespiratory fitness, physical endurance, muscle strength, cognitive function, and health-related quality of life. The primary objective is to determine the impact of the remotely supervised combined aerobic and resistance exercise on incidence and severity of NACT-related adverse effects in patients with BC.
Eligibility criteria
Qualifiers
previously untreated primary breast cancer;
stage IIA-B, IIIA-C at diagnosis;
diagnosis established by core needle biopsy;
age 30-65 years;
Disqualifiers
cardiac pathologies (assessed by echocardiogram);
blood transfusion in the last six months;
another oncological disease;
previous chemotherapy, hormonal or X-ray treatment;
Trial design
Treatments tested in this trial
- Intervention Group
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov